Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma.
Miguez S, Lee RY, Chan AX, Demkowicz PC, Jones BSCL, Long CP, Abramson DH, Bosenberg M, Sznol M, Kluger H, Goldbaum MH, Francis JH, Pointdujour-Lim R, Bakhoum MF.
Miguez S, et al.
Ophthalmology. 2023 Jun;130(6):598-607. doi: 10.1016/j.ophtha.2023.01.020. Epub 2023 Feb 4.
Ophthalmology. 2023.
PMID: 36739981
PURPOSE: To validate the prognostic usefulness of gene expression profile (GEP) testing in patients with uveal melanoma. ...Patients with class 2 tumors showed an observed 5-year MFS of 47.5% (95% CI, 36.0%-62.8%). CONCLUSIONS: Tumor size …
PURPOSE: To validate the prognostic usefulness of gene expression profile (GEP) testing in patients with uvea …